According to the latest report by IMARC Group, titled "Parenteral Nutrition Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global parenteral nutrition market reached a value of US$ 6.3 Billion in 2021. Parenteral nutrition (PN) refers to the method of feeding essential nutrients into the vein. It is widely utilized for patients who are unable to absorb nutrients via the intestinal tract due to underlying diseases. It is an intravenous administration of nutrition that include various essential nutrients required for healthy development, such as carbohydrate, protein, electrolytes and minerals, fat and vitamins. As a result, it is required for patients suffering from certain ailments, such as severe acute pancreatitis, bowel obstruction, short bowel syndrome and gastrointestinal (GI) fistulas.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Parenteral Nutrition Market Trends:
The global market is primarily driven by the increasing prevalence of chronic digestive disorders among the masses. Coupled with the rising occurrence of malnutrition, the growing premature births and natality rates, and the increasing geriatric population, this is providing a boost to the market. Along with this, the widespread adoption of parenteral nutrition over enteral nutrition during the onset of coronavirus disease (COVID-19) has significantly supported the market growth on the global level. Since parenteral nutrition offers several benefits, including shorter hospital stays and reduced risk of infection, this is creating a positive market outlook. Additionally, continual technological advancements, such as the introduction of advanced parenteral nutrition products with barcode assistance, are impacting the market favorably. Other factors, including continuous improvements in the healthcare infrastructure and extensive research and development (R&D) activities conducted by key players, are also positively influencing the market. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 9.3 Billion by 2027, exhibiting a CAGR of 6.77% during 2022-2027.
- On the basis of the nutrient type, the market has been segmented into carbohydrates, lipid emulsion, single dose amino acid solution, trace elements, and vitamins and minerals.
- Based on the end-user, the market has been segregated into hospitals, clinics and others.
- On the basis of the region, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Latin America (Brazil, Mexico and others) and the Middle East and Africa.
- The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Some of the key players are Aculife Healthcare Private Limited, B. Braun Melsungen AG, Baxter International Inc., Fresenius SE & Co. KGaA, Grifols S.A., Otsuka Pharmaceutical Factory Inc., Pfizer Inc. and Servona GmbH.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Follow us on twitter : @imarcglobal